Skip to content

LFMD

LifeMD, Inc.

NASDAQ · Healthcare · Medical - Pharmaceuticals · US

$3.23
+0.78%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$0.14
Revenue estimate
$48.9M

Latest reported

Last report date
Aug 5, 2026
EPS actual
-$0.16
EPS estimate
-$0.15
Revenue actual
$47.3M
Revenue estimate
$49.2M

Track record

Trailing twelve quarters

EPS beats (12Q)
8
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-20.1%
Revenue beats (12Q)
5

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$8.67
PT range
$8.00 – $9.00
Analysts
3
3 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026-$0.15-$0.16Miss -9.81%$47.3M
May 6, 2026-$0.14-$0.20Miss -42.86%$50.2M
Mar 9, 2026-$0.07-$0.04Beat 39.13%$6.0M
Nov 17, 2025-$0.06-$0.10Miss -66.67%$60.2M
Mar 10, 2025-$0.04-$0.02Beat 50.00%$64.3M
Nov 7, 2024-$0.10-$0.14Miss -40.00%$40.3M
Mar 11, 2024-$0.14-$0.12Beat 14.29%$44.9M
May 12, 2023-$0.16-$0.15Beat 6.25%$33.1M
Mar 22, 2023-$0.18$0.02Beat 111.11%$28.1M
Nov 10, 2022-$0.27-$0.03Beat 88.89%$31.4M
Aug 11, 2022-$0.23-$0.22Beat 4.35%$30.5M
May 13, 2022-$0.26-$0.25Beat 3.85%$29.0M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026